Related Experiment Video
Updated: Feb 25, 2026
09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
7.1K
Heart failure - what's new and what's changed?
Paul D Callan1, Andrew L Clark2
1Advanced Heart Failure and Cardiac Transplantation, University Hospital of South Manchester, Manchester, UK paulcallan843@btinternet.com.
Clinical Medicine (London, England)
|August 3, 2017
Summary
Novel therapies are needed for heart failure with left ventricular systolic dysfunction, despite existing treatments. This review discusses adaptive servo-ventilation, a diabetic agent, and sacubitril valsartan, alongside care management guidelines.
Area of Science:
- Cardiology
- Heart Failure Research
- Clinical Trials
Background:
- Heart failure with left ventricular systolic dysfunction (LVSD) remains a significant cause of morbidity and mortality.
- Despite advances, there is a persistent need for innovative therapeutic strategies.
- Current evidence-based treatments prolong life and alleviate symptoms but do not fully address the condition's burden.
Purpose of the Study:
- To review recent advancements and ongoing research in heart failure management.
- To discuss the implications of key clinical trials for heart failure specialists.
- To highlight the importance of integrated care models for heart failure patients.
Main Methods:
- Review of findings from the SERVE-HF trial on adaptive servo-ventilation in LVSD.
- Analysis of the EMPA-REG study concerning a novel diabetic agent's effects on heart failure.
- Examination of further analyses from the PARADIGM-HF trial on sacubitril valsartan.
Main Results:
- SERVE-HF investigated adaptive servo-ventilation for heart failure patients.
- EMPA-REG explored a novel diabetic agent's potential benefits in heart failure.
- PARADIGM-HF analyses addressed unresolved questions regarding sacubitril valsartan efficacy.
Conclusions:
- Ongoing research is crucial for developing novel therapies for heart failure.
- Evidence from trials like SERVE-HF, EMPA-REG, and PARADIGM-HF informs treatment strategies.
- Well-organized, multidisciplinary care is essential for managing the growing heart failure population.
Related Concept Videos
01:30Heart Failure V: Medical Management
400
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
400
01:22Heart Failure VI: Adjunct Therapies
442
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442
01:17Pathophysiology of Heart Failure
4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
476
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
476
01:29Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
01:30Heart Failure VII: Nursing Interventions
580
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
580